SCHEMBL24313682

SCHEMBL24313682

CCOc1ccc(C(C)C)cc1[S+]([O-])NC(=O)c1cc2c(F)cc(C3CC3)cc2o1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
MAPT P10636 2/20 0.33
MEN1 O00255 4/20 0.33
KMT2A Q03164 4/20 0.33
NPSR1 Q6W5P4 2/20 0.32
PDK2 Q15119 1/20 0.32
KCNH2 Q12809 7/20 0.32
MCHR1 Q99705 7/20 0.32
KDM4E B2RXH2 1/20 0.31
CCR5 P51681 1/20 0.31
LMNA P02545 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
HTR1A P08908 1/20 0.31
ADRA2A P08913 1/20 0.31
ADORA3 P0DMS8 1/20 0.31
CYP2C9 P11712 1/20 0.31
ADRA2B P18089 1/20 0.31
HTR2C P28335 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24314303 0.94 MEN1 (0.35) ALDH1A1MAPTMEN1KMT2ANPSR1
SCHEMBL24314223 0.92 PDE4A (0.34) PDK2KCNH2MCHR1ACACB
SCHEMBL24313680 0.91 KCNH2 (0.39) ALDH1A1SMN1; SMN2NPSR1KCNH2MCHR1
SCHEMBL24314317 0.91 PDK2 (0.37) PDK2HTR1ASLC6A4
SCHEMBL24314235 0.90 KCNH2 (0.36) ALDH1A1MAPTMEN1KMT2AKCNH2
SCHEMBL24314313 0.90 ACACB (0.36) ACACB
SCHEMBL24314217 0.88 PDE4D (0.31)
SCHEMBL24313754 0.88 MEN1 (0.36) ALDH1A1SMN1; SMN2MAPTMEN1KMT2A
SCHEMBL24313761 0.87 MEN1 (0.32) ALDH1A1MAPTMEN1KMT2ANPSR1
SCHEMBL24313977 0.87 CYP1A2 (0.37) ALDH1A1MEN1KMT2AKCNH2MCHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022081842-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed